The HLA Single Antigen Bead Assay for Class I IgG Antibodies, commonly referred to as the DSA-SAB Class I Test, is a highly specialized laboratory procedure designed to detect and identify specific donor-specific antibodies (DSAs) against Class I HLA antigens. These antibodies can play a significant role in the rejection of transplanted organs and are crucial markers for assessing the compatibility between organ donors and recipients. The test employs a sophisticated technique that uses microbeads coated with purified HLA antigens to accurately identify the presence and specificity of IgG antibodies targeting HLA Class I molecules.
Conducted at DNA Labs UAE, this test is pivotal for patients undergoing or considering organ transplantation, as the presence of DSAs can significantly affect the outcome and longevity of the transplant. By identifying these antibodies, healthcare providers can make informed decisions about donor selection, immunosuppressive therapy, and post-transplant management to improve transplant success rates and patient outcomes.
The cost of the DSA-SAB Class I Test at DNA Labs UAE is 5150 AED. This investment in testing is crucial for ensuring the best possible match between donor and recipient, thereby enhancing the chances of transplant success and long-term health benefits for patients requiring organ transplants.
The Oncopro BRAF Rapid Test is a cutting-edge diagnostic tool designed to identify mutations in the BRAF gene, which are implicated in various forms of cancer, including melanoma, colorectal cancer, and thyroid cancer. This test is particularly significant for guiding the treatment plan for patients, as BRAF mutations can influence the response to specific targeted therapies.
Performed at DNA Labs UAE, a leading facility in genetic testing and personalized medicine, the Oncopro BRAF Rapid Test employs advanced molecular techniques to ensure accurate and swift results. The test is priced at 5150 AED, reflecting the sophisticated technology and expertise involved in its execution.
By opting for this test, patients and healthcare providers can make informed decisions regarding the most effective treatment strategies, potentially improving outcomes and quality of life for those affected by BRAF-mutant cancers.
The Chromosomal Microarray (CMA) 750K High Resolution Test is a cutting-edge genetic test offered by DNA Labs UAE, designed to detect chromosomal abnormalities with unparalleled precision. This test examines the entire genome at a high resolution of 750,000 markers, allowing for the identification of microdeletions and duplications that traditional karyotyping methods might miss. These anomalies can be linked to a wide range of genetic disorders and developmental delays, making this test a valuable tool for early diagnosis and intervention.
With a cost of 2500 AED, the CMA 750K High Resolution Test is an investment in obtaining a comprehensive genetic overview, which can be particularly beneficial for individuals with unexplained developmental issues, autism, intellectual disabilities, or congenital anomalies. Conducted at the state-of-the-art facilities of DNA Labs UAE, this test requires a simple blood sample from which DNA is extracted and analyzed. The results provide detailed insights into one's chromosomal health, offering a roadmap for personalized medical management and informed family planning decisions.
The "CNGA3 Gene Achromatopsia Type 2 Genetic Test" is a specialized diagnostic tool designed to detect mutations in the CNGA3 gene, which are responsible for Achromatopsia Type 2, a rare genetic disorder affecting vision. This condition is characterized by partial or total absence of color vision, light sensitivity, involuntary eye movements, and significantly reduced visual acuity. The test is crucial for accurate diagnosis, enabling personalized management and genetic counseling for affected individuals and their families. Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test offers reliable results, leveraging advanced genomic technologies. The cost for undergoing this genetic test is 3600 AED, reflecting the comprehensive analysis and expert interpretation that accompanies this service.
The CNGB3 gene achromatopsia type 3 genetic test is a specialized diagnostic tool designed to identify mutations in the CNGB3 gene, which are known to cause achromatopsia type 3. Achromatopsia is a rare, inherited eye condition characterized by partial or total absence of color vision, light sensitivity, and reduced visual acuity. This condition results from mutations in several genes, including CNGB3, which plays a critical role in the normal functioning of cone cells in the retina responsible for color vision.
The test involves collecting a DNA sample, typically through a blood draw or cheek swab, and analyzing it for specific genetic alterations in the CNGB3 gene. Identifying these mutations can confirm a diagnosis of achromatopsia type 3, allowing for appropriate management and genetic counseling for affected individuals and their families.
This genetic test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The cost of the CNGB3 gene achromatopsia type 3 genetic test is 4400 AED. This investment in genetic testing can be crucial for families seeking answers about this condition, as it not only aids in diagnosis but also helps in understanding the inheritance pattern, potential risks to other family members, and considerations for future pregnancies.
The GNAT2 Gene Achromatopsia Type 4 Genetic Test is a specialized diagnostic tool designed to detect mutations in the GNAT2 gene, which are responsible for causing Achromatopsia Type 4. Achromatopsia is a rare inherited vision disorder characterized by total or partial absence of color vision, light sensitivity, and markedly reduced visual acuity. The GNAT2 gene plays a crucial role in the normal functioning of cone cells in the retina, which are essential for color vision. Mutations in this gene disrupt the normal processing of visual signals, leading to the symptoms associated with Achromatopsia Type 4.
This genetic test involves analyzing the patient's DNA to identify mutations in the GNAT2 gene. It is a critical tool for confirming the diagnosis of Achromatopsia Type 4, enabling appropriate management and genetic counseling for affected individuals and their families. The test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates.
The cost of the GNAT2 Gene Achromatopsia Type 4 Genetic Test at DNA Labs UAE is 4400 AED. This price may include the collection of a DNA sample, usually through a blood draw or cheek swab, the genetic analysis, and a comprehensive report of the findings. Patients considering this test should consult with their healthcare provider to understand the implications of the results and discuss any concerns they may have about the genetic testing process.
The PDE6H gene achromatopsia type 6 genetic test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the PDE6H gene, which are linked to achromatopsia type 6. Achromatopsia is a rare, inherited eye condition characterized by partial or total absence of color vision, light sensitivity, and reduced visual acuity. The test plays a crucial role in the accurate diagnosis and understanding of this specific type of achromatopsia, enabling tailored patient care and management strategies.
DNA Labs UAE, known for its advanced genetic testing services, performs this test with precision and reliability. The cost of the test is set at 4400 AED, reflecting the intricate processes and sophisticated technology involved in detecting the genetic variations associated with the condition. Through this test, individuals and families gain valuable insights into their genetic makeup, paving the way for informed decisions regarding treatment options and lifestyle adjustments to better manage the condition.
The CACNA1F gene plays a critical role in the proper functioning of the retina, the light-sensitive tissue at the back of the eye. Mutations in this gene are associated with Aland Island Eye Disease (AIED), a rare X-linked genetic disorder that affects males more severely than females. AIED is characterized by a range of visual impairments, including reduced visual acuity, nystagmus (involuntary eye movement), and abnormalities in color vision.
To diagnose this condition, DNA Labs UAE offers a genetic test specifically targeting the CACNA1F gene. This test is crucial for identifying mutations in the CACNA1F gene that are responsible for Aland Island Eye Disease. By analyzing a small sample of the patient's DNA, the test can confirm the presence of the genetic mutation associated with AIED, thus providing a definitive diagnosis.
The cost of the CACNA1F gene test at DNA Labs UAE is 4400 AED. This comprehensive testing service not only aids in the diagnosis of Aland Island Eye Disease but also plays a pivotal role in guiding the management and treatment of affected individuals. Additionally, it can be instrumental in genetic counseling for families affected by this condition, helping them understand the risks of transmission to future generations.
The GPR143 gene, associated with Ocular Albinism Type I, also known as Nettleship-Falls Type Albinism, plays a crucial role in determining the pigmentation of the eyes, skin, and hair. Mutations in this gene can lead to a reduction in melanin production, which is characteristic of this condition, leading to visual problems and light sensitivity. The genetic test for this specific type of albinism focuses on identifying mutations within the GPR143 gene to confirm a diagnosis, guide treatment, and inform family planning decisions.
At DNA Labs UAE, a specialized test is available for those suspected of having Ocular Albinism Type I (Nettleship-Falls Type). This test is meticulously designed to detect the presence of mutations in the GPR143 gene, offering a critical tool for accurate diagnosis and management of the condition. The cost of the test is 4400 AED, reflecting the comprehensive nature of the analysis and the advanced technology utilized to ensure precise results. This test is an invaluable resource for affected individuals and their families seeking clarity on their genetic status and looking to understand the implications for their health and vision.
The SLC24A5 gene plays a critical role in the pigmentation of the skin, hair, and eyes, and mutations in this gene can lead to a form of albinism known as oculocutaneous albinism type 6 (OCA6). OCA6 is a nonsyndromic genetic condition, meaning it primarily affects pigmentation and does not significantly impact other bodily systems. Individuals with OCA6 typically present with lighter skin and hair color compared to non-affected family members, and may also experience vision problems, which are common in albinism due to the lack of melanin in the eyes.
Recognizing the importance of accurate diagnosis and understanding of this condition, DNA Labs UAE offers a genetic test specifically targeting the SLC24A5 gene to identify mutations associated with OCA6. The test is a crucial tool for families seeking to understand their genetic makeup, particularly for those with a history of albinism, as it can provide definitive confirmation of the condition and guide future family planning decisions.
The cost of the SLC24A5 gene albinism oculocutaneous nonsyndromic genetic test at DNA Labs UAE is 4400 AED. This test is conducted with state-of-the-art technology to ensure high accuracy and reliability of results. Upon completion, individuals receive a comprehensive report that not only details the presence of any mutations in the SLC24A5 gene but also offers insights into the implications of these genetic findings. This information can be invaluable for affected individuals and their families, offering them a clearer understanding of the condition and how to manage it moving forward.
